Medical Device Executives Nailed with Fraud Charges
The three Magellan Diagnostics executives are accused of FDA violations, as well as wire fraud and conspiracy.
The three Magellan Diagnostics executives are accused of FDA violations, as well as wire fraud and conspiracy.
Recent Advisory Opinion sheds light on offering patients financial assistance so they can receive the provider’s products and services.
This week’s cases involved false billing allegations related to urine drug testing, as well as diagnostic imaging false claims and fraud.
The owners face fraud charges in two different schemes, one involving urine drug testing and one involving COVID-19 testing.
New Advisory Opinion 23-01 is similar to other arrangements the OIG has approved in the past.